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ARTICLE
Genome-wide CRISPR screen identifies host
dependency factors for influenza A virus infection
Bo Li1,2, Sara M. Clohisey 3, Bing Shao Chia1,2, Bo Wang 3, Ang Cui2,4, Thomas Eisenhaure2,
Lawrence D. Schweitzer2, Paul Hoover2, Nicholas J. Parkinson3, Aharon Nachshon 5, Nikki Smith3,
Tim Regan 3, David Farr3, Michael U. Gutmann6, Syed Irfan Bukhari7, Andrew Law 3, Maya Sangesland8,
Irit Gat-Viks2,5, Paul Digard 3, Shobha Vasudevan7, Daniel Lingwood8, David H. Dockrell9, John G. Doench 2,
J. Kenneth Baillie 3,10* & Nir Hacohen 2,11*
Host dependency factors that are required for influenza A virus infection may serve as
therapeutic targets as the virus is less likely to bypass them under drug-mediated selection
pressure. Previous attempts to identify host factors have produced largely divergent results,
with few overlapping hits across different studies. Here, we perform a genome-wide CRISPR/
Cas9 screen and devise a new approach, meta-analysis by information content (MAIC) to
systematically combine our results with prior evidence for influenza host factors. MAIC out-
performs other meta-analysis methods when using our CRISPR screen as validation data. We
validate the host factors, WDR7, CCDC115 and TMEM199, demonstrating that these genes are
essential for viral entry and regulation of V-type ATPase assembly. We also find that CMTR1,
a human mRNA cap methyltransferase, is required for efficient viral cap snatching and
regulation of a cell autonomous immune response, and provides synergistic protection with
the influenza endonuclease inhibitor Xofluza.
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Influenza A Virus (IAV) causes acute respiratory infectionsin humans and poses a major threat to public health andthe global economy. The 2009 H1N1 pandemic resulted in
over 60 million infected cases in the United States1 and more than
120,000 deaths worldwide, the majority of which were in young
people (<65 years old)2. Avian influenza strains like the H5N1
and H7N9 have also crossed the species barrier and caused lethal
infections in humans in recent years3–5, raising concerns for
future pandemics. Although vaccination against seasonal influ-
enza is an essential part of the public health strategy, its efficacy is
variable, and there are few therapeutic options for people who
become infected. Conventional antiviral therapies including
neuraminidase inhibitors (e.g., oseltamivir, zanamivir) and M2
channel blockers (e.g., amantadine) have limited efficacy and are
vulnerable to the rapid selection of resistant virus in treated
patients6–8. A new class of endonuclease inhibitor (Xofluza) has
been approved recently9, but faces similar issues with emergence
of resistance viral strains10.
Like most viruses, IAV has a relatively small genome and
limited repertoire of encoded proteins11 and relies on the host
machinery to replicate and complete its life cycle. Identification of
host dependency factors (HDFs) that are necessary for IAV
replication thus provides an attractive strategy for discovering new
therapeutic targets, since the evolution of resistance to host-
targeted therapeutics is expected to be slower12–14. To achieve this
end, numerous large-scale RNA interference (RNAi) screens have
been performed in the past, reporting a total of 1362 HDFs that
are important for IAV replication15–21. While these screens pro-
vided valuable insights into viral-host interactions22–24, overlap in
the identified hits has been limited25, a result that likely stemmed
from differences in experimental conditions as well as intrinsic
limitations in the RNAi technology. A similar inconsistency is
evident among screens for HDFs required for HIV infection26–28.
In recent years, many groups have successfully utilized
CRISPR/Cas9 as an alternative screening strategy for HDFs in
viral infections29–33. A recently published genome-wide CRISPR/
Cas9 screen based on cell survival after IAV infection uncovered a
number of new HDFs involved in early IAV infection, but shared
few hits with previous RNAi screens. This raises the question
whether CRISPR- and RNAi-based screens are confined to
identifying mutually exclusive targets due to technological biases.
To more comprehensively identify IAV-host interactions, we
perform pooled genome-wide CRISPR/Cas9 screens and use IAV
hemagglutinin (HA) protein expression on the cell surface as a
phenotypic readout. We identify an extensive list of IAV HDFs,
including new and previously known factors, involved in various
stages of the IAV life cycle. We focus on the less understood host
factors and discover that loss ofWDR7, CCDC115, and TMEM199
results in lysosomal biogenesis and over-acidification of the endo-
lysosomal compartments, which blocks IAV entry and increases
degradation of incoming virions. We also identify the human 2′O-
ribose cap methyltransferase, CMTR1 as an important host factor
for IAV cap snatching and regulator of cell autonomous immune
surveillance. To link our findings to previously identified IAV
HDFs, we devise a new approach, meta-analysis by information
content (MAIC), to combine data from diverse sources of
unknown quality, in the form of ranked and unranked gene lists.
MAIC performs better than other algorithms for both synthetic
data and in an experimental test, and provides a comprehensive
ranked list of host genes necessary for IAV infection.
Results
Influenza host dependency factors identified in a CRISPR
screen. To identify HDFs that are necessary for IAV infection, we
performed two independent rounds of pooled genome-wide
CRISPR screens in A549-Cas9 cells using the well-established
AVANA4 lentivirus library34, which encodes 74,700 sgRNAs
targeting 18,675 annotated protein-coding genes (with 4 sgRNAs
per gene), as well as 1000 non-targeting sgRNAs as controls. On
day 9 post-transduction with the library, we infected ~300 million
puromycin-resistant cells with influenza A/Puerto Rico/8/1934
(PR8) virus at multiplicity of infection (MOI) 5 for 16 h. Cells
were sorted by FACS into different bins based on their levels of
surface viral HA (Fig. 1a), which should reflect the efficiency of
the viral life cycle from entry to HA export. Roughly ~5% of the
cells were sorted into the uninfected bin (low HA expression);
these were compared to a control population of cells (comprising
the mode for HA expression+/− 20% of the population). Cells
that harbor genetic alterations restricting influenza virus repli-
cation (i.e., sgRNAs that target host genes important for infec-
tion) are expected to be enriched in the uninfected bin. For
analysis of the screen data, we combined the empirical p-values
which sums the evidence in support of over-representation of
sgRNAs targeting a given gene. This method optimizes the dis-
covery power of the screen and is more reproducible than two
other common analysis approaches—STARS and MAGeCK
(Supplementary Fig. 1, Supplementary Note 1). In this initial
screen, sgRNAs targeting 41 genes were significantly enriched in
the uninfected bin relative to control bin (FDR < 0.05) (Supple-
mentary Data 1, Fig. 1b).
To validate identified hits (and thus reduce false positives)
and recover additional hits (minimize false negatives), we
performed a secondary pooled screen targeting the top 1000
ranked hits from the primary screens but with 10 sgRNAs per
gene. We re-identified 37 out of the 41 hits that scored with
FDR < 0.05 in the primary screen, as well as recovering
additional hits that failed to meet the original FDR cutoff
(Fig. 1c). Combining data from the primary and secondary
screens yielded a final list of 121 genes (FDR < 0.05) whose roles
have been shown or predicted in different stages of the IAV life
cycle (Fig. 2, Supplementary Data 1). Amongst these, 78 genes
showed significant enrichment of two or more sgRNAs in the
uninfected bin, while 43 genes had enrichment for only a single
sgRNA. We included the latter in our analysis in order to
maximize the discovery power for subsequent validation, and
because many of these genes have also been identified in
previous RNAi screens and proteomics studies.
The significantly-enriched genes from the primary and
secondary screens included both known HDFs from previous
RNAi screens such as ATPase subunits, components of the
vesicular transport pathway, signal recognition particles, and
genes involved in sialic acid synthesis, as well as unknown ones
like components of the TRAPP and TREX2 complexes, genes
involved in protein prenylation and co-factors of V-type
ATPases. Unlike the previous RNAi screens, we found relatively
few ribosomal subunits and genes involved in translation and
splicing among our top ranked hits, suggesting that CRISPR-
mediated editing of essential host factors potently reduces cell
survival, such that cells bearing these edits did not survive the
8 days between editing and influenza virus challenge.
Meta-analysis by information content (MAIC). To incorporate
these findings into the existing evidence base, which include
annotated pathways23,35, genetic perturbation screens16,33,36, and
protein–protein interactions, we devised the MAIC approach to
evaluate the information content in each data source by com-
paring it to other data sources. MAIC takes a simple and intuitive
approach to quantify the information content in a given list of
genes, for example the results of a single experiment, by com-
paring it to the results of other experiments that might reasonably
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be expected to find some of the same genes. In this way MAIC
produces a weighting factor for each experiment, and then cal-
culates a score for each gene. Our analysis then produced a final
ranked list of HDFs based on this score, which summarizes the
composite evidence from all input sources of a particular gene
being involved in IAV infection (Supplementary Data 2). We
found that our CRISPR/Cas9 screen provides the most infor-
mation (11.4% of total information content) when compared with
individual genetic perturbation screens and proteomics studies
performed in the past (Fig. 1d).
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We performed extensive in silico validation of the MAIC
method using synthetic data designed to test MAIC when
presented with combinations of ranked and unranked data,
varying levels of noise, and varying levels of heterogeneity of data
quality in the input data sets. We compared MAIC to two existing
approaches: (1) a simple count of the number of occurrences of
each gene in each data set, and (2) robust rank aggregation
(RRA), a powerful method for aggregating ranked data (such as
screen results), which does not allow for the inclusion of
unranked data (such as a pathway or coexpression cluster)37.
MAIC performs better than both methods under most condi-
tions; in the absence of noise (when every single item in the input
dataset is correct), MAIC performs similarly to other methods
(Fig. 1e, Supplementary Fig. 2).
In order to provide an experimental test of the MAIC
algorithm, we used MAIC to combine relevant data sources from
the literature (Supplementary Note 2), with the exception of the
new data from our CRISPR screen. We then used the CRISPR
screen as an unseen “gold standard”, against which to test other
siRNA screens and meta-analysis. Both MAIC and RRA
successfully prioritize highly-ranked genes in the top 50 CRISPR
hits, but RRA fails to identify hits below this level (Fig. 1f). In
contrast, a simple count of the occurrences of each gene in each
category (vote counting) fails to prioritize the top candidates, but
is more effective at identifying many genes in the top 1000 ranks.
This is in part due to the dominance of protein interaction data in
the MAIC results (Fig. 1g). The MAIC algorithm outperforms
both RRA and vote-counting, and prioritizes more genes that
overlap with CRISPR results than any other data source (RNAi
screens and protein interaction studies), including a previous
gene-level meta-analysis36 (Fig. 1g). MAIC thus identifies a
unique set of host factors based on multiple lines of evidence, and
distinct from the ranked list of any individual screen (Supple-
mentary Data 2). Ribosomal genes feature heavily in the MAIC
results because of strong support from several datasets. As
expected, genes with a variety of other functions, including host
antiviral response, RNA processing and proteasome function are
also highly supported. Gene set enrichment analysis (GSEA)
highlights afferent signaling pathways, including Toll-like recep-
tor signaling (KEGG; Supplementary Data 2), and EGF and
MAPK signaling and related pathways (BioCarta; Supplementary
Data 2).
Validation of influenza host factor dependencies. We selected
28 genes for further validation based on their top ranking in our
screen and not being previously implicated in IAV infection.
A549 cells were transduced with the top 2 sgRNAs from the
secondary screen (based on fold change of sgRNA in uninfected
bin relative to control bin) and genome editing was confirmed by
sequencing of the predicted target sites. Polyclonal KO cells were
then infected with Influenza A PR8 virus at MOI 5 on day 9 post-
sgRNA transduction and stained for surface HA. We found 21
out of the 28 polyclonal KO cell lines to be partially protected
against IAV infection for both sgRNAs (Supplementary Fig. 3),
while three polyclonal KO cell lines were protected for only one
of the two tested sgRNAs. The degree of protection varied
between the cell lines despite their sgRNAs having comparable
genome editing efficiency (Supplementary Fig. 4), suggesting the
roles of these genes differ depending on the cell context.
Deletion of four of the hits—WDR7, CCDC115, TMEM199,
and CMTR1—conferred strong protection against PR8 virus
infection in both A549 cells and normal human lung fibroblasts
(NHLFs) (>40% reduction in percentage of HA-positive cells)
(Fig. 3a, b). To test if the four genes are required for efficient virus
production, we infected WDR7, CCDC115, TMEM199, and
CMTR1 polyclonal KO cells with H1N1 PR8 virus and H3N2
Udorn virus at MOI 0.1 and monitored virus production at 24,
48, and 72 h post-infection by plaque assay. Virus production
peaked after 48 hours post-infection for PR8 virus and 24 h post-
infection for Udorn virus. At these time points, we observed >2
log reduction in virus titer in all four polyclonal KO cell lines for
PR8 virus and >1 log reduction in for Udorn virus compared to
wild type cells (Fig. 3c). The greater magnitude of reduction in
viral infection rate observed at low MOI is likely due to
cumulative effects of multiple replication cycles. We also
compared the phenotype of knocking out WDR7, CCDC115,
TMEM199, and CMTR1 to SLC35A1, a known IAV host factor
that was both highly-ranked in ours and previous published
CRISPR/Cas9 screens33. SLC35A1 is a CMP-sialic acid transpor-
ter that is required for surface sialic acid expression and IAV
entry. We observed similar reduction in percentage of HA-
positive cells and virus titer produced by infected WDR7,
CCDC115, TMEM199, and CMTR1 KO cells compared to
SLC35A1 KO cells (Supplementary Fig. 5A-E). The degree of
protection conferred by CRISPR deletion of these genes is also
consistent with what is previously published for polyclonal
SLC35A1 KO cells33, suggesting that these genes may indeed
serve as important IAV HDFs.
Since PR8 and Udorn are lab-adapted IAV strains, we also
tested the infectivity of WDR7, CCDC115, TMEM199, and
CMTR1 polyclonal KO cells by more recent clinical isolates of
IAV including the 1999 New Caledonia and 2009 California
H1N1 pandemic strains, as well as a H5N1 IAV strain (Vietnam/
2004) that has been re-engineered with PR8 internal genes.
Similar to previous observation with PR8 and Udorn virus, we
showed that A549 cells lacking WDR7, CCDC115, TMEM199 or
CMTR1 again displayed lower levels of IAV HA RNA at 16 h
post-infection compared to control cells by qRT-PCR (Fig. 3d).
Fig. 1 Genome-wide CRISPR screens identify IAV host dependency factors. a Schematics of the genome-wide CRISPR/Cas9 screening strategy.
b, c Spatial distribution of CRISPR knockout signals on the genome for the primary and secondary screens. b Gene-level p-values in primary screen. A
selection of top hits is highlighted. c Gene-level FDRs for top hits in the secondary screen. The core set of 121 robust hits (FDR < 0.05) is shown highlighted
in red. d Representation of shared information content between each data source after MAIC analysis. Size of data source blocks is proportional to the
summed information content (MAIC scores) of input list. Lines are colored according to the dominant data source. Data source categories share the same
color; the largest categories and data sources are labeled (see supplementary information for full source data). CRISPR screen performed in this study is
labeled as CRISPR (viral production). e Example of validation of MAIC screen using synthetic data (see methods). Y-axes show overlap ratio compared to a
known truth (see methods; narrow line= average of 100 replicates; shading= 95% confidence interval). MAIC consistently out-performs existing methods
(robust rank aggregation, RRA; vote counting; VC) when presented realistic inputs. Example shown is for a mixture of ranked and unranked data sources,
and moderate variation in data quality (heterogeneity) between data sources. See supplementary Figs. 2 for full evaluation. f Experimental validation of
MAIC (computed without CRISPR data) against an unseen gold standard (CRISPR screen). Plot shows number of overlaps with the top 1000 hits in CRISPR
screen for a given position in each ranked dataset. g Contribution of different data categories to predictive value of the MAIC. As in (f), graph shows
number of overlaps with the top 1000 CRISPR screen hits. Results are shown with all RNAi data from previous studies removed from the input set, and with
all proteomic or protein interaction data removed. The results of the systematic meta-analysis by Tripathi et al.36 are shown for comparison.
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To confirm that the observed phenotype is not due to off-
target effects, we expressed codon-mutated versions of these
genes in the polyclonal KO cells and observed restoration of
normal IAV infection levels (Supplementary Fig. 6A, Supple-
mentary Fig. 6B) in all the KO cells with the exception of
WDR7 KO cells, which is only partially rescued. We speculated
that this could be due to the large protein size of WDR7 which
makes it difficult to express (173kDA). To confirm that the
phenotype type observed for WDR7 is not due to off-target
effects, we tested two additional sgRNAs against WDR7 and
observed similar reduction in IAV infection rate (Supplemen-
tary Fig. 6C). To test if the functions of these genes apply to
other viruses, we infected the four polyclonal KO cell lines with
vesicular stomatitis virus (VSV) and showed that WDR7,
CCDC115, and TMEM199, but not CMTR1 were also required
for efficient VSV infection (Fig. 3e).
0 20 40 60 80
10–1
100
101
105
106
107
108
101
100
10–1
102
104
105
106
h.p.i
PF
U/
m
l
PR8 virus titer
0 20 40 60 80
h.p.i
PF
U/
m
l
Udorn virus titer
TMEM199 sgRNA
CMTR1 sgRNA
Non-targeting sgRNA
WDR7 sgRNA
CCDC115 sgRNA
0 2 4 6 8 10
0
50,000
100,000
150,000
200,000
250,000
Day
Ce
ll n
um
be
r
CMTR1 sgRNA
ATP6V1A sgRNA
Non-targeting sgRNA
Proliferation
WDR7 sgRNA
CCDC115 sgRNA
TMEM199 sgRNA
****
********
****
****
****
****
****
a b
c
d
f
****
****
****
ns
e
No
n-t
arg
etin
g (N
T)
WD
R7
 sg
RN
A
CC
DC
11
5 s
gR
NA
TM
EM
19
9 s
gR
NA
CM
TR
1 s
gR
NA
0
50
100
%
 o
f H
A+
 c
el
ls
n
o
rm
a
liz
ed
 to
 N
T
H1N1(PR8)
No
n-t
arg
etin
g (N
T)
WD
R7
 sg
RN
A
CC
DC
11
5 s
gR
NA
TM
EM
19
9 s
gR
NA
CM
TR
1 s
gR
NA
0
50
100
%
 o
f G
FP
+ 
ce
lls
n
o
rm
a
liz
ed
 to
 N
T
Normal human lung fibroblast  (NHLF)
No
n-t
arg
etin
g (N
T)
WD
R7
 sg
RN
A
CC
DC
11
5 s
gR
NA
TM
EM
19
9 s
gR
NA
CM
TR
1 s
gR
NA
0
20
40
60
80
100
120
%
 o
f G
FP
+ 
ce
lls
n
o
rm
a
liz
ed
 to
 N
T
VSV
No
n-t
arg
etin
g (N
T)
WD
R7
 sg
RN
A
CC
DC
11
5 s
gR
NA
TM
EM
19
9 s
gR
NA
CM
TR
1 s
gR
NA
SL
C3
5A
1 S
gR
NA
No
n-t
arg
etin
g (N
T)
WD
R7
 sg
RN
A
CC
DC
11
5 s
gR
NA
TM
EM
19
9 s
gR
NA
CM
TR
1 s
gR
NA
SL
C3
5A
1 S
gR
NA
No
n-t
arg
etin
g (N
T)
WD
R7
 sg
RN
A
CC
DC
11
5 s
gR
NA
TM
EM
19
9 s
gR
NA
CM
TR
1 s
gR
NA
SL
C3
5A
1 S
gR
NA
0.0
0.5
1.0
1.5
Fo
ld
 c
ha
ng
e 
in
H
A 
R
N
A 
no
rm
al
iz
ed
 to
 N
T
IAV HA RNA H1N1/California/2009
H1N1/NewCaledonia/1999
H5N1/Vietnam/2004/PR8
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13965-x
6 NATURE COMMUNICATIONS |          (2020) 11:164 | https://doi.org/10.1038/s41467-019-13965-x | www.nature.com/naturecommunications
To test if these genes are essential for cell survival, we
monitored the proliferation rate of A549 cells up to 9 days post-
transduction with WDR7, CCDC115, TMEM199, and
CMTR1 sgRNAs. We observed no significant difference in
proliferation rate between these cells compared to those
transduced with non-targeting sgRNA (Fig. 3f). In contrast,
majority of the cells transduced with sgRNA against ATP6V1A, a
V-type ATPase subunit and a known IAV host factor, died by day
7 post-transduction. Annexin V straining also confirmed a similar
number of live cells between A549 cells transduced with WDR7,
CCDC115, TMEM199, and CMTR1 sgRNAs and non-targeting
sgRNA on day 9 post-transduction (Supplementary Fig. 6D).
Thus, the four identified genes were critical for IAV infection but
not observed to impact cell viability.
WDR7, CCDC115, TMEM199, and CMTR1 involved in early
infection. To better understand how loss of these genes con-
ferred resistance against IAV infection, we first determined
which steps of the IAV life cycle they play a role in. We found
significant reduction in viral nucleoprotein (NP) RNA and
protein levels at 4 h post-infection in WDR7, CCDC115,
TMEM199, and CMTR1 polyclonal KO cells compared to wild
type cells, suggesting that all 4 genes are important during early
infection (Fig. 4a)38. To test if the genes are required for IAV
entry, we infected polyclonal KO cells with MLV-GFP retro-
virus pseudotyped with H1N1 PR8 HA and NA proteins. This
allows the retrovirus to enter the cell in a HA dependent
manner that is akin to IAV entry39. We then monitored GFP
expression in the cells 48 h post-infection. We found that
WDR7, CCDC115 and TMEM199 KO cells, but not CMTR1
KO cells had lower percentage of GFP-expressing cells com-
pared to wild type (Fig. 4b). In contrast, all four polyclonal KO
cell lines had comparable GFP expression to wild type cells
when infected with an MLV-GFP retrovirus pseudotyped with
amphotropic MLV-envelope protein, suggesting that WDR7,
CCDC115 and TMEM199 are specifically required for IAV
entry in a HA/NA dependent manner. We next asked if the
three genes were required for IAV entry by allowing virus
attachment to the cell surface membrane. To test this, we
incubated polyclonal KO cells with PR8 virus at 4 °C for 30 min
(to prevent viral fusion), followed by washing and staining for
surface bound HA. We found no difference in HA staining
between the KO and wild type cells, suggesting that the genes
are not essential for virus attachment (Fig. 4c). This is also
supported by the observation that WDR7, CCDC115, and
TMEM199 did not affect expression of cell surface sialic acids
(Fig. 4c), which serve as entry receptors for IAV40. In contrast,
A549 cells that have undergone CRISPR deletion of SLC35A1
have both reduced levels of surface sialic acid and bound
virions.
WDR7, CCDC115, and TMEM199 regulate endo-lysosomal
pH. Recent studies have reported WDR7, CCDC115, and
TMEM199 as factors associated with mammalian V-type
ATPases41,42, but their functions remain unclear. To test if
these genes are required for IAV entry by regulating endo-
lysosomal acidification, we stained WDR7, CCDC115,
TMEM199, and CMTR1 polyclonal KO cells with lysotracker red,
fluorescent-labeled anti-Rab7 and anti-LAMP1 antibodies.
Unexpectedly, we observed an increase in lysotracker red staining
in WDR7, CCDC115, and TMEM199 KO cells, which co-stained
partly with Rab7 (late endosome) and LAMP1 (lysosome).
(Fig. 5a). To determine if the increase in lysotracker red staining
is solely due to expansion of the endo-lysosomal compartments
or actual reduction in pH, we also stained the cells with the more
pH-sensitive lysosensor blue dye and Oregon Green Dextran. As
in the case with lysotracker red, we observed an increase in
lysosensor blue staining and reduction in Oregon Green signal
(Oregon Green fluorescence becomes quenched at lower pH) in
WDR7, CCDC115 and TMEM199 KO cells, indicating that both
endo-lysosomal expansion and reduction in pH were taking place
(Supplementary Fig. 7A). A similar increase in lysotracker
staining is observed in NHLFs transduced with WDR7,
CCDC115, and TMEM199 sgRNAs (Supplementary Fig. 7B). We
next asked if this reduction in endo-lysosomal pH could be
restored in WDR7, CCDC115, and TMEM199 polyclonal KO
cells by treating the cells with Bafilomycin A (BafA), a known
inhibitor of V-type ATPase activity43 and IAV infection44. We
observed a reduction in lysotracker staining in KO cells treated
with BafA treatment (Fig. 5b), suggesting that these genes func-
tion upstream of V-type ATPases. However, we found that BafA
treatment, even at low concentrations, further protected the KO
cells against IAV infection (Fig. 5c, Supplementary Fig. 8A). We
speculated that this may be due to disruption of the fine pH
gradient in the endocytic pathway that is required for efficient
IAV uncoating and replication45. WDR7, CCDC115 and
TMEM199 appeared to play non-redundant roles as over-
expression of WDR7 in CCDC115 or TMEM199 polyclonal KO
cells and vice versa did not rescue IAV infection rate (Supple-
mentary Fig. 8B). Over-expression of WDR7, CCDC115 and
TMEM199 in wild type A549 cells also did not have an effect on
lysotracker staining or IAV infectivity, suggesting that their
effects on function may already be saturated at the steady state
(Supplementary Fig. 8C, Supplementary Fig. 8D).
To understand how loss of WDR7, CCDC115, and TMEM199
resulted in expansion and over-acidification of the endo-
lysosomal compartments, we extracted cytosolic and membra-
nous proteins from the polyclonal KO cells and measured the
relative abundance of the cytosolic V1A and transmembrane V0D
domain subunits of the V-type ATPases via western blot46. We
observed an enrichment of V1A subunit in the cytosolic fraction
Fig. 3 Validation of screen hits in A549 cells and normal human lung fibroblasts (NHLF). a A549 cells and b primary normal human lung fibroblasts
were transduced with either gene-specific or non-targeting sgRNA, followed by infection with PR8 virus at MOI 5 for 16 h. Y-axis shows percentage of HA-
positive cells normalized to non-targeting sgRNA. Error bars represent standard deviations from three independent experimental replicates. c Virus titer in
plaque forming units (PFU)/ml at 24, 48, and 72 h post-infection with either PR8 (Left) or Udorn (right) virus at MOI 0.1. Supernatant used for the plaque
assay was collected from infected A549 cells transduced with either gene-specific or non-targeting sgRNA. Error bars represent standard deviations from
three independent experimental replicates. d Fold change in viral HA RNA level relative to GAPDH measured by qRT-PCR. A549 cells transduced with
either gene-specific or non-targeting sgRNA were infected with H1N1 California/2009, H1N1/New Caledonia/1999 or H5N1/Vietnam/2004/PR8-
recombinant IAV strains at high MOI for 16 h. Fold change was normalized to HA RNA level in A549 cells transduced with non-targeting sgRNA. A549
cells transduced with SLC35A1 sgRNA was used for comparison. Error bars represent standard deviations from three independent experimental replicates.
e A549 cells transduced with either gene-specific or non-targeting sgRNA were infected with VSV-GFP virus at MOI 1 for 16 h. Y-axis shows percentage
of GFP-positive cells normalized to non-targeting sgRNA. Error bars represent standard deviations from three independent experimental replicates.
f Proliferation curve of transduced A549 cells up to 9 days post sgRNA-transduction. Error bars represent standard deviations from three independent
experimental replicates. ****P= 0.0001 ***P < 0.001 and *P < 0.05, by one-way ANOVA test.
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of WDR7, CCDC115 and TMEM199 KO cells and a correspond-
ing reduction in the membrane fraction, indicating that at least a
subset of V-type ATPases are in a dis-assembled and less active
state in these cells (Fig. 5d). This was unexpected as inactivation
of the V-type ATPase should in theory lead to less endo-
lysosomal acidification. It has been reported that prolonged
treatment of cells with lysosomotropic compounds such as
chloroquine and tamoxifen could lead to increased lysotracker
red staining due to lysosome adaptation and biogenesis caused by
nuclear translocation of transcription factor EB (TFEB)47,48
(Supplementary Fig. 9A). To test if absence of WDR7, CCDC115
or TMEM199 leads to TFEB translocation and lysosomal
biogenesis, we extracted cytosolic and nuclear proteins from
WDR7, CCDC115, and TMEM199 polyclonal KO cells and
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Fig. 4 WDR7, CCDC115, TMEM199 and CMTR1 are involved in early infection. a Flow cytometry and fluorescent in situ hybridization (FISH) for influenza
PR8 NP protein and RNA. A549 cells were transduced with either gene-specific or non-targeting sgRNA and infected with PR8 virus for 4 h. Infected cells
were stained with anti-H1N1 NP antibody or NP FISH RNA probes. Bar graphs show quantification for the percentage of NP-positive cells for both protein
and RNA (cells with positive FISH staining) normalized to non-targeting sgRNA. Scale bar= 20 μm. Error bars represent standard deviation from three
independent experimental replicates for NP protein staining and four randomly chosen frames for NP RNA FISH. b A549 cells were transduced with either
gene-specific or non-targeting sgRNA and infected with MLV-GFP reporter virus pseudo-typed with either influenza PR8 HA and NA or MLV envelop
proteins. Y-axis shows percentage of GFP-positive cells normalized to non-targeting sgRNA. Error bars represent standard deviations from three
independent experimental replicates. c Histogram showing level of surface-bound HA (left) and sialic acid (right). A549 cells transduced with either gene-
specific or non-targeting sgRNA were incubated with PR8 virus for 30min at 4 °C for monitoring level of surface-bound HA or stained with fluorescein-
labeled Sambucus Nigra Lectin for 1 h at 4 °C for surface sialic acid. Cells transduced with sgRNA targeting SLC35A1 was used as positive control.
Histograms shown is representative of three independent experimental replicates. ****P= 0.0001 ***P < 0.001 and **P < 0.01, by one-way ANOVA test.
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Fig. 5 WDR7, CCDC115 and TMEM199 regulate endo-lysosomal pH. a Immunofluorescence of A549 cells transduced with either gene-specific or non-
targeting sgRNA and stained with Lysotracker red, anti-LAMP1 and anti-Rab7 antibodies. Scale bar= 20 μm. b Lysotracker red staining of A549 cells
transduced with either gene-specific or non-targeting sgRNA. Cells were mock-treated or treated with 100 nM Bafilomycin A (BafA). Scale bar= 20 μm.
c A549 cells transduced with either gene-specific or non-targeting sgRNA were treated with different concentrations of BafA followed by PR8 virus
infection. Error bars represent standard deviations from two independent experimental replicates. d A549 cells transduced with either gene-specific or
non-targeting sgRNA were fractioned into membrane and cytosolic components. The two fractions were then subjected to SDS-PAGE and Western
blotting using antibodies against subunit A of the V1 domain and subunit D of the V0 domain as measure of V-ATPase assembly. Western blotting was also
performed for HSP90 (cytosolic) and COX-IV (membrane) as positive controls. e Cytosolic and nuclear proteins were extracted from A549 cells
transduced with either gene-specific or non-targeting sgRNA using the NE-PER Nuclear and Cytoplasmic extraction kit. Samples in each fraction were
subjected to SDS-PAGE and western blotting using antibodies against TFEB. Western blotting for TATA-binding protein (TBP) was used as positive control.
f Whole cell lysates were extracted from A549 cells transduced with either gene-specific or non-targeting sgRNA. Samples were subjected to SDS-PAGE
and western blotting using antibodies against TFEB and Phospho-TFEB (ser211).
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measured the relative abundance of TFEB in each fraction. We
observed an enrichment of TFEB in the nuclear fraction of
WDR7, CCDC115 and TMEM199 KO cells but not in CMTR1
KO or wild-type cells (Fig. 5e). There was also de-
phosphorylation of TFEB at Ser211 in WDR7, CCDC115, and
TMEM199 KO cells, which is required for TFEB dissociation
from the lysosomal surface and subsequent nuclear transloca-
tion49 (Fig. 5f). Sequencing of bulk RNA from the KO cells also
showed an increase in expression of lysosomal genes including
ASAH1, NPC2, Cathepsin B, and Cathepsin L (Supplementary
Fig. 9B)50. These led us to conclude that the loss of WDR7,
CCDC115, and TMEM199 results in V-type ATPase inactivation
which in turn triggers compensatory lysosomal adaptation and
biogenesis. Since Bafilomycin A treatment reduced lysotracker
red staining in WDR7, CCDC115 and TMEM199 KO cells, we
speculated that different isoforms of V-type ATPase or other
ATPases (P- or F-type) may play a compensatory role in these
cells when one or more V-type ATPases become inactivated.
Loss of WDR7, CCDC115 or TMEM199 prevents IAV nuclear
entry. While it is known that an acidic endo-lysosomal environment
is required for IAV entry51, we showed that expansion of the endo-
lysosomal compartment and reduction in pH also block IAV
infection in WDR7, CCDC115, and TMEM199 KO cells. To assess
the functional effect of lysosomal adaptation, we incubated WDR7,
CCDC115 and TMEM199 polyclonal KO cells with DQ-Green BSA,
a derivative of bovine serum albumin (BSA) that is heavily labeled
with green fluorescent BODIPY FL dye. The dye is usually self-
quenched but produces a bright fluorescence when DQ-Green BSA
is cleaved by hydrolases in the acidic endo-lysosomal compart-
ments52. We found that WDR7, CCDC115, and TMEM199 poly-
clonal KO cells exhibited brighter DQ-BSA staining than CMTR1
KO cells and wild type cells, which co-stained with the increased
lysotracker red signal. This suggested that there is increased endo-
lysosomal trafficking and degradation of incoming endocytic cargo
in cells lacking WDR7, CCDC115 or TMEM199 (Fig. 6a).
To test if incoming IAV virions are being trafficked to and
degraded in the endo-lysosome compartments, we infected poly-
clonal KO cells with PR8 virus at MOI 500 and stained for
intracellular NP protein at 2 h post-infection. In wild type cells, NP
staining was bright and primarily observed in the nuclei, where viral
replication takes place. In contrast, NP staining was largely absent in
the nuclei of WDR7, CCDC115, and TMEM199 KO cells and was
instead concentrated in punctate structures near the peri-nuclear
regions (Fig. 6b). The NP punctate structures co-stained partly with
LAMP1, suggesting that at least a sub-fraction of the incoming
virions are retained in the lysosomes. In contrast, NP staining was
also reduced in CMTR1 KO cells but found in the nuclei like in wild
type cells. Taken together, these suggested that incoming virions are
blocked prior to nuclear entry and are likely retained in the endo-
lysosomal compartments due to lack of viral fusion.
Although an acidic endo-lysosomal environment is required
for viral fusion, studies have shown that exposure to pH lower
than the optimal fusion pH may cause HA inactivation and
coagulation of viral ribonucleoproteins (RNP)53–55. In addition,
perturbation of V-type ATPase activity and localization can
disrupt the pH gradient from early to late endosomes56 which
IAV requires for efficient uncoating57. To test if the block in IAV
infection is due to sub-optimal fusion pH, we compared the
infectivity of two different H3N2 viral strains in the polyclonal
KO cells. The X:31 strain has been shown to initiate membrane
fusion at a lower pH and is more acid stable than the Udorn
strain53. We thus hypothesized that X:31 virus will be less affected
by the lower endo-lysosomal pH in WDR7, CCDC115, and
TMEM199 polyclonal KO cells than Udorn virus. Consistent with
this, we observed comparable viral NP RNA levels in KO and wild
type cells at 16 h post-infection by X:31 virus. In contrast, KO
cells have significantly lower viral RNA levels compared to wild
type cells when infected with Udorn virus (Fig. 6c).
CMTR1 is required for IAV cap snatching. CMTR1 was
recently discovered as the human 2′-O-ribose cap
methyltransferase58,59, which adds a methyl-group to the 5′-7
methylguanosine cap of eukaryotic mRNA to form the
Cap1 structure (methylation of the 2′-O ribose of the first tran-
scribed nucleotide). Since 2′-O-methylation of the mRNA cap has
been known to be important for IAV cap snatching60,61, we
hypothesized that loss of CMTR1 would inhibit viral transcrip-
tion by preventing efficient cap snatching. To test this, we
transfected WDR7, CCDC115, TMEM199 and CMTR1 poly-
clonal KO cells with a vRNA luciferase reporter construct car-
rying PR8 promoter and UTR regions, as well as plasmids
expressing PR8 polymerase subunits PA, PB1 and PB262. Twenty-
four hours post-transfection, the cells were lysed and luciferase
activity was measured. Consistent with our hypothesis, we
observed lower luciferase activity in CMTR1 KO cells but not in
WDR7, CCDC115, TMEM199 KO cells or wild-type cells
(Fig. 7a).
To test the hypothesis that CMTR1 is involved in IAV cap
snatching, we infected wild type and CMTR1 polyclonal KO cells
with PR8 virus and immuno-precipitated the cell lysate with anti-
eIF4E antibody to pull down capped viral and host RNA63.
Relative abundance of pulled-down NP RNA in CMTR1 KO and
wild type cells was then measured by qRT-PCR. Our results
showed that while there was no difference in amount of NP RNA
pulled down by anti-IgG control, there was significantly more NP
RNA pulled down by anti-eIF4E antibody in wild type cells
compared to CMTR1 KO cells, suggesting that the latter has less
capped viral RNA (Fig. 7b). Since eIF4E binds to both cap0 and
cap1 RNA, while IAV only efficiently cap snatch cap1 RNA, we
normalized the amount of pulled-down NP RNA (cap1) against
GAPDH (cap0+ cap1). We then compared this ratio between
wild type and CMTR1 KO cells in anti-eIF4E and anti-IgG
pulldown samples. We found that CMTR1 KO cells have a lower
ratio of NP: GAPDH than wild type cells (Fold change= 0.29) in
anti-eIF4E pulldown samples but not in anti-IgG control (Fig. 7b).
Importantly, we found this difference to be more pronounced
than that observed for un-precipitated input samples (fold
change= 0.53), suggesting that the difference observed between
CMTR1 KO cells and wild type cells is not just due to inhibition
of viral replication. Together, these observations led us to
conclude that CMTR1 is required for efficient IAV cap snatching.
Loss of CMTR1 increases expression of anti-viral genes.
Although Cap1 is present on most eukaryotic mRNAs, its precise
functions are poorly understood as the lack of CMTR1 does not
seem to have a significant impact on global protein translation58.
Recent studies have proposed that 2-O-ribose methylation of the
mRNA cap acts as a mechanism by which the cell differentiates
between self- and non-self RNA64,65, as siRNA knockdown of
CMTR1 was shown to elevate Type I IFN response in A549 cells
in the absence of additional stimulus. We hypothesized that the
loss of CMTR1 may block IAV infection by both preventing
efficient cap snatching and increasing cell autonomous antiviral
responses. To test the latter, we measured the transcript levels of
the anti-viral cytokine, IFN-β, in CMTR1 polyclonal KO cells and
wild type cells in the presence and absence of PR8 infection via
qRT-PCR. Interestingly, we observed an increase in IFN-β
expression in CMTR1 KO cells but only when they were infec-
ted by PR8 virus (Fig. 7c), despite lower level of viral NP RNA
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detected in CMTR1 KO cells compared to wild type cells (Sup-
plementary Fig. 10A). We also observed lower level of NS1 RNA
in infected CMTR1 KO cells, which may help to explain the
increase in IFN signatures in these cells. To confirm our results,
we extracted RNA from CMTR1 KO cells and wild type cells with
and without PR8 infection and performed bulk RNA sequencing.
Principal component analysis (PCA) revealed significant differ-
ences in RNA expression profile between CMTR1 KO cells and
wild type cells in the presence of PR8 infection but not at the
resting state (Supplementary Fig. 10B). A closer inspection of the
differentially-expressed genes showed an enrichment of Type I
and II IFN-related genes as well as other antiviral genes in
CMTR1 KO cells (Fig. 7d). To test if the increase in IFN signature
is mediated by the RIG-I sensing pathway66, we transduced
CMTR1 KO cells with sgRNA targeting RIG-I, MAV or IRF3
followed by infection with influenza PR8 virus. We found that the
increase in IFN- β expression isield completely abrogated in the
absence of RIG-I, MAV or IRF3, indicating that an intact RNA
sensing pathway is required for the elevated IFN response in
CMTR1 KO cells (Fig. 7e).
Synergistic action between CTMR1 knockout and Xofluza. The
recent FDA-approved drug Xofluza (Baloxavir Marboxil) blocks
IAV infection by inhibiting the endonuclease activity of IAV PA
subunit and preventing cap snatching9,10. To test if CMTR1 has
potential interactions with Xofluza, we pre-treated WDR7,
CCDC115, TMEM199, and CMTR1 polyclonal KO cells with
increasing doses of Baloxavir (active form of the drug) prior to PR8
virus infection and measured changes in infectivity. While all four
KO cell lines and wild type cells displayed a dose-dependent
N
on
-ta
rg
et
in
g
W
D
R
7 
sg
RN
A
CC
DC
11
5 
sg
RN
A
TM
EM
19
9 
sg
RN
A
CM
TR
1 
sg
RN
A
DQ-BSALysotracker Combined
N
P
Co
m
bi
ne
d
LA
M
P1
Non-targeting WDR7 sgRNA TMEM199 sgRNACCDC115 sgRNA CMTR1 sgRNA
a b
c
***
*
***
No
n-t
arg
etin
g
WD
R7
–/–
CC
DC
11
5–
/–
TM
EM
19
9–
/–
CM
TR
1–
/–
0
1
2
3
4
DQ-BSA degradation
Fl
uo
re
sc
en
ce
 in
te
ns
ity
/c
el
l
ns
UD
OR
N X3
1
0.0
0.5
1.0
1.5
Fo
ld
 c
ha
ng
e 
in
 v
ira
l N
P 
RN
A
n
o
rm
a
liz
ed
 to
 N
T
WDR7 sgRNA
CCDC115 sgRNA
TMEM199 sgRNA
Non-targeting
***
***
***
ns
ns
ns
Fig. 6 Loss of WDR7, CCDC115 and TMEM199 prevents IAV nuclear entry. a Immunofluorescence staining of A549 cells transduced with either gene-
specific or non-targeting sgRNA with DQ-green bovine serum albumin (BSA) and Lysotracker red. Cells were treated with 20ug/ml DQ-BSA and
Lysotracker red for 1 h at 37 °C followed by fixation to monitor uptake and hydrolysis of the DQ-BSA. DQ-BSA staining was quantified by dividing
total fluorescence intensity by the number of cells in each frame. Bar graph shows the relative fluorescence intensity between different sgRNAs. Scale
bar= 20 μm. Error bars represent standard deviation from three randomly chosen frames. b Immunofluorescent staining of A549 cells transduced with
either gene-specific or non-targeting sgRNA with FITC-conjugated anti-H1N1 NP antibody. Cells were infected with PR8 virus at MOI 500 for 2 h at 37 °C.
Scale bar= 15 μm. c Fold change in viral NP RNA level relative to GAPDH measured by qRT-PCR. A549 cells transduced with gene-specific or non-targeting
sgRNA were infected with either influenza H3N2 Udorn or X31 virus at MOI 5 for 16 h. Fold change was normalized to viral NP RNA level in A549 cells
transduced with non-targeting sgRNA. Error bars represent standard deviations from three independent experimental replicates. ***P < 0.001 and *P < 0.05,
by one-way ANOVA test.
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reduction in viral infection rate, CMTR1 KO cells demonstrated the
most drastic decrease in infectivity with increasing dose of Baloxavir
treatment (Fig. 7f). At the lowest concentration of drug adminis-
tered (5 nM), CMTR1 KO cells had a 85% reduction in infectivity
compared to 40%, 45%, 23% and 6% achieved in WDR7,
CCDC115, TMEM199 KO cells and wild-type cells respectively.
This indicated that loss of CMTR1 may confer synergistic protec-
tion against IAV infection with Xofluza treatment.
Discussion
In this study, we identified 121 host genes that are required for
IAV replication based on our CRISPR screen. In addition, we
devised and applied the MAIC algorithm to put these discoveries
in the context of extensive previous literature on this topic,
generating a ranked list of all known HDFs for influenza.
Unlike many earlier host factor screens that relied on cell
survival as selection criterion, we adopted a different CRISPR/
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Fig. 7 Loss of CMTR1 inhibits viral replication and up-regulates anti-viral genes. a A549 cells transduced with gene-specific or non-targeting sgRNAs
were transfected with PR8 PA, PB1, PB2, and NP plasmids together with green-Renilla and Luciferase reporter plasmids for 24 hours. Luciferase activity was
measured and normalized to A549 cells transduced with non-targeting sgRNA. Error bars represent standard deviations from three independent
experimental replicates. b A549 cells transduced with CMTR1 or non-targeting sgRNA were infected with PR8 virus, in vivo crosslinked, lysed and
immunoprecipitated with either anti-eIF4E or anti-IgG antibody to extract capped cellular and viral RNA. qRT-PCR was performed to monitor the relative
abundance of PR8 NP RNA. (Left): Fold change in NP RNA levels normalized to anti-IgG non-targeting sgRNA pulldown. (Right): Fold change in NP relative
to GAPDH RNA levels normalized to non-targeting sgRNA. Error bars represent standard deviations from three independent experimental replicates. c Fold
change in IFN- β relative to GAPDH mRNA levels measured by qRT-PCR. A549 cells transduced with CMTR1 or non-targeting sgRNA were either mocked
treated, infected with PR8 virus or treated with 200 U/ml IFN- β for 16 h. Fold change was normalized to A549 cells transduced with non-targeting sgRNA.
Error bars represent standard deviations from three independent experimental replicates. d Gene Ontology (GO) enrichment analysis showing the top 10
up-regulated gene categories in A549 cells transduced with CMTR1 sgRNA versus non-targeting sgRNA after PR8 virus infection. IFN-related and antiviral
gene categories are colored in red. e Fold change in IFN- β relative to GAPDH mRNA levels measured by qRT-PCR. A549 cells were transduced with
CMTR1 sgRNA alone or together with sgRNA targeting RIG-I, MAV or IRF3 and infected with PR8 virus. Fold change was normalized to cells transduced
with non-targeting sgRNA. Error bars represent standard deviations from three independent experimental replicates. f A549 cells transduced with gene-
specific or non-targeting sgRNA were pre-treated with 0, 1, 5 or 10 nM of Baloxavir followed by PR8 virus infection. Y-axis shows the percentage of
HA-positive cells normalized to untreated cells. Error bars represent standard deviations from three independent experimental replicates. ****P= 0.0001,
**P < 0.01, by one-way ANOVA test.
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Cas9 screening strategy by using viral protein expression at an
early time point post-infection as our phenotypic readout. Using
such a continuous metric allowed us to identify a deeper set of
HDFs (121 hits with FDR < 0.05) that play roles from early to late
stages of the IAV life cycle. A significant fraction of our hits (77/
121 hits) overlapped with those from previous RNAi screens and
proteomics studies (Supplementary Data 3), including all six
genes that were identified in at least four RNAi screens
(ATP6AP1, ATP6V0C, ATP6V0D1, COPA, COPG, and
NXF1)25. This differed from a previous published CRISPR/Cas9
cell survival screen which identified primarily early entry factors
and shared few common hits with RNAi screens, suggesting that
endpoint selection can strongly affect screening outcomes.
Importantly, both our CRISPR/Cas9 screen and the recently
published one33 identified shared HDFs absent from previous
RNAi screens, indicating that our knowledge of IAV-host inter-
actions had not yet reached saturation.
By deriving an information content weighting directly from the
overlap between input data sets, the MAIC algorithm provided a
systematic meta-analyses of multiple experiments and other data
sources of unknown quality, aggregated both ranked and
unranked data sources, and outperformed other methods in
realistic comparisons using synthetic data, and in an experimental
comparison using our CRISPR screen as a validation dataset. The
ability to combine ranked and unranked data, and to system-
atically weight input data by a data-driven quality metric, over-
comes some limitations of previous work36,37. Interestingly, our
meta-analysis highlighted many relevant hits found in the Dro-
sophila RNAi screen16 compared with other RNAi screens. In
contrast, we found that there was relatively little relevant infor-
mation content detected among a set of human genes under
recent positive selection67. The MAIC approach revealed many
HDFs supported by CRISPR or siRNA evidence, with strong
evidence supporting a direct interaction with viral proteins, but
with no existing annotation in the KEGG35 or FluMap68 data-
bases. Strongly-supported examples include the PRPF8 gene,
which has recently been shown by another group to have a dose-
dependent relationship with influenza virus expression69, as well
as numerous genes, such as the splicing factor SRSF6 and the
elongation factor EEF1A1 which have not, to our knowledge, been
studied in influenza virus infection models. MAIC thus highlights
genes that are strongly supported by evidence to play important
roles in IAV infections, but have not been extensively studied
previously.
We focused on genes highly ranked in our screen but not
previously investigated in the context of IAV infection for func-
tional follow-up experiments. Three of our top ranked hits from
the CRISPR screens,WDR7, CCDC115 and TMEM199, have been
reported as putative V-type ATPase-associated co-
factors41,42,70,71, but their functions in mammalian cells and
especially in the context of viral infections are poorly understood.
Here, we provide evidence that all three genes are required for
efficient V-type ATPase assembly and IAV entry. Unlike V-type
ATPase subunits, knocking out WDR7, CCDC115 or TMEM199
did not result in loss of cell viability, suggesting that these co-
factors could serve as better therapeutic targets.
The unexpected observation that WDR7, CCDC115, and
TMEM199 polyclonal KO cells underwent expansion and over-
acidification of the endo-lysosomal compartments led us to
hypothesize that long-term inhibition of V-type ATPases may
cause a compensatory increase in lysosomal function, a phe-
nomenon that is observed in cells that were subjected to starva-
tion or prolonged treatment with lysosomoptropic
compounds47,72. In support of this, we observed increased
nuclear translocation of TFEB and expression of lysosomal genes
in WDR7, CCDC115, and TMEM199 KO cells. A previous study
reported that knockdown of RNASEK, another V-type ATPase-
associated factor, also led to increased endo-lysosomal acidifica-
tion that was mediated by the P-type ATPase ATP13A273,
suggesting that other ATPase proteins may over-compensate for
the inactivation of specific V-type ATPases. TFEB over-
expression has been postulated as potential treatment for a
variety of human diseases74–76. Our observation that TFEB-
mediated expansion and over-acidification of endo-lysosomal
compartments block IAV and VSV infection opens the possibility
of upregulating TFEB activity as a treatment option for reducing
acid-dependent viral infections.
While it has been established that an acidic endosomal
environment is required for IAV entry51,77, we showed that
depletion of WDR7, CCDC115, and TMEM199 increases endo-
lysosomal acidification, yet reduces viral infection. We hypo-
thesized that this could be due to two reasons: First, it has been
reported that exposure to pH that is too acidic could lead to HA
inactivation and inhibition of viral fusion53,55. In support of
this, we showed that incoming virions were trapped in punctate
structures around the perinuclear regions of WDR7, CCDC115,
and TMEM199 polyclonal KO cells, which partially co-stained
with LAMP1. We also observed increased degradation of
endocytic cargo in these cells, suggesting that incoming virions
which failed to fuse could be targeted for degradation in the
endo-lysosomes. In addition, we found that X:31 virus, a more
acid stable H3N2 strain than the Udorn virus53, retained nor-
mal infection rates in WDR7, CCDC115 and TMEM199 poly-
clonal KO cells. Second, sequential exposure to lower pH from
the early to late endosome has been shown to be required for
productive IAV infection45,57. Depletion of WDR7, CCDC115,
and TMEM199 may thus block IAV infection by disrupting the
pH gradient in the endo-lysosome pathway56. Here, we showed
that BafA treatment, while reducing lysotracker red staining,
did not restore IAV infection in WDR7, CCDC115, and
TMEM199 polyclonal KO cells. The lysotracker red signal in
the KO cells also co-stained with both late endosome and
lysosome markers, indicating possible homogenization of pH
across different endosomal compartments.
IAV relies on a unique strategy of cap-snatching to carry out
viral transcription and replication78. The PA subunit of the IAV
polymerase complex functions as a cap-dependent endonuclease,
which recognizes and cleaves short fragments of capped host
mRNA to use as primer for its own mRNA synthesis79. Although
it has been long appreciated that 2′O-ribose methylation of the
host mRNA cap is required for efficient recognition and cleavage
by PA60,61, no cap methyltransferase had been identified in IAV
genetic screens to date. In this study, we discovered CMTR1 as an
important IAV HDF, whose absence confers resistance against
IAV infection by blocking viral cap snatching. We also observed
that depletion of CMTR1 resulted in increased IFN response in
IAV-infected cells. Unlike a previous study which showed that
siRNA knockdown of CMTR1 causes up-regulation of IFN-β in
the absence of additional stimulation65, we found differential
expression of type I IFN and IFN-stimulated genes (ISGs) only
when the cells were infected with IAV. We speculate that this is
due to their use of siRNA, which could lead to siRNA-induced
innate immune sensing by RIG-I/MDA5. The lack of immune
activation in CMTR1 KO cells at resting state makes it a good
drug candidate due to its therapeutic window and low risk of
autoimmunity. Previous studies have shown that the IFIT family
of antiviral proteins sequester 2′-O-unmethylated capped RNA
and block viral protein translation80,81. Coincidentally, we
observed an increase in IFIT gene expression in CMTR1 poly-
clonal KO cells, suggesting that inhibition of viral replication
might be attributed to both cap snatching blockade and direct
sequestration of viral RNA.
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The advantage of targeting IAV cap snatching as a therapeutic
strategy is best highlighted by the recent FDA approval of Xofluza
(Baloxavir Marboxil), a small molecule drug that inhibits the
endonuclease function of PA9,10,55,82. A single dose of Xofluza
treatment has been shown to accelerate symptom alleviation and
reduce viral load to a greater extent compared to the neur-
aminidase inhibitor Oseltamivir. Despite its effectiveness, resis-
tant viral strains with reduced susceptibility to Xofluza have
already been isolated in cell culture and clinical trials, raising
concerns for long term administration of the drug9,83. Given that
CMTR1 is required for efficient viral cap snatching, we tested for
potential interaction between CMTR1 and Baloxavir. Our results
provided preliminary evidence that depletion of CMTR1 confers
synergistic protection again IAV infection with Baloxavir treat-
ment. A combination therapy targeting both host CMTR1 and
IAV endonuclease may thus serve as an attractive therapeutic
option given greater barrier against drug resistance.
In conclusion, our study has identified and validated a number
of HDFs that play important roles during IAV infection. We
show that WDR7, CCDC115, and TMEM199 regulate V-type
ATPase assembly and their absence causes compensatory
expansion and over-acidification of the endo-lysosomal com-
partments, which hamper IAV entry. We also report CMTR1 as a
novel HDF that is required for efficient viral cap snatching and
regulation of cell autonomous immune response. Lastly, our
MAIC algorithm consolidates data from all previous genetic
screens and proteomics studies and generates an annotated list of
IAV HDFs which can serve as useful resource for future studies.
Methods
Cell culture, reagents, and virus strains. A549, A549-Cas9, and 293T cells were
cultured in Dulbecco’s Modified Eagle Medium (DMEM, Thermofisher) supple-
mented with 10% heat-inactivated fetal bovine serum (Sigma), 2 mM L-Glutamine
(Gibco) and 1% penicillin. A549 and 293T cells were obtained from ATCC. A549-
Cas9 cell line was generated by transducing A549 cells with a lentiviral construct
(pXPR101) expressing Cas9 and Blasticidin deaminase. Cas9 activity was con-
firmed by transducing A549-Cas9 cells with a lentiviral construct (pXPR_011-
sgEGFP) expressing eGFP and an sgRNA specific for eGFP. Polyclonal population
of the A549-Cas9 cell line was used for the CRISPR screen to maintain hetero-
geneity of the cells. Primary NHLF cells were cultured in Mesenchymal Stem Cell
Growth Medium (MSCGM, Lonza). PR8/A/34, A/Udorn/72 and A/Aichi/68 (X:31)
Influenza A viruses were grown in MDCK cells in serum-free DMEM supple-
mented with 1% BSA and 1 μg/ml TPCK trypsin. GFP-Vesicular stomatits virus
(VSV) was kindly.pngted by Dr. Sean Whelan’s lab. Influenza A/New Caledonia/
20/1999, A/California/04/2009 and A/Vietnam/1203/2004-PR8-IBCDC-RG/GLP
viruses were kindly.pngted by Dr. Daniel Lingwood’s lab. Bafilomycin A1 was
obtained from invivogen (88899-55-2). Chloroquine diphosphate was obtained
from Sigma (C6628). Baloxavir was obtained from MedChemExpress (HY-
109025A).
Plasmids. pXPR101 and pXPR_011-sgEGFP used to generate A549-Cas9 cells and
pLentiGuide-puro (Addgene #52963) for secondary screen were provided by the
Broad Institute Genetic Perturbation Platform. Individual sgRNAs were cloned
into pLentiCRISPR-V2(Addgene #52961) and pXPR_004 (Puromycin resistance
gene in pLentiCRISPR-V2 was replaced by eGFP) for validation in A549 cells and
NHLFs respectively. For rescue experiments, the Cas9 gene in pXPR101 was
replaced by codon-mutated versions of WDR7, CCDC115, TMEM199, and
CMTR1 genes (pXPR101_rescue). For pseudovirus production, we used MLV Gag-
pol, GFP, PR8 HA, PR8 NA, and MLV Env plasmids (kindly provided by Michael
Farzan and Wayne Marasco).
Antibodies. The following antibodies were used throughout this study: From EMD
Millipore, Anti-Influenza A HA (AB1074) (1:200), FITC Anti-Influenza A
Nucleoprotein clone A1 (MAB8257F) (1:200). From Abcam, Anti-LAMP1 clone
H4A3 (ab25630) (1:100), Anti-Rab7 Alexa-Fluor647 clone EPR7589 (ab198337)
(1:100), Anti-ATP6V0D1 (ab56441) (1:2000), β-actin antibody (ab6276) (1:10000).
From BD bioscience, FITC mouse anti-human CD71 (555536) (1:100). From
Thermofisher, Alexa-Fluor488 Goat anti-mouse IgG (1:500), Alexa-Fluor488
Donkey anti-goat IgG (1:500). From Sigma Aldrich, Anti-Flag M2 antibody
(F3165) (1:2000). From Cell Signaling Technology, TFEB antibody (#4240S)
(1:2000), Phospho-TFEB antibody (Ser211) (#37681S) (1:2000), Cox-IV antibody
(4850s) (1:2000), HSP90 antibody (#4874) (1:2000) and TBP antibody (#8515)
(1:2000). From Abnova, Anti-ATP6V1A (H00000523-A01) (1:2000).
Pooled genome-wide CRISPR screen. Hundred million A549-Cas9 cells were
transduced with the AVANA-4 lentiviral library34 to achieve 40% infection rate
and average 500-fold coverage of the library after selection. After 24 h, the cells
were selected with puromycin and an initial pool of 40 million cells were harvested
for genomic DNA extraction using the Qiagen Blood and Tissue extraction kit
according to manufacturer protocol. On day 9 post-transduction, 200–400 million
puromycin resistant A459-Cas9 cells were infected with Influenza A PR8 virus at
MOI5 for 16 h. They were then washed and stained with florescent anti-Influenza
A HA (AB1074) antibody. HA-positive and HA-negative cells were sorted by FACS
and harvested for genomic DNA. PCR of gDNA was performed in 100 μl reactions
to attach sequencing adaptors and barcode samples. Each reaction consisted of 50
μL gDNA plus water, 40 μL PCR master mix and 10 μL of a uniquely barcoded P7
primer (stock at 5 μM concentration). Master mix comprised of 75 μL ExTaq DNA
Polymerase (Clontech), 1000 μL of 10x Ex Taq buffer, 800 μL of dNTP provided
with the enzyme, 50 μL of P5 stagger primer mix (stock at 100 μM concentration),
and 2075 μL water. PCR cycling conditions: an initial 1 min at
95 °C; followed by 30 s at 94 °C, 30 s at 52.5 °C, 30 s at 72 °C, for 28 cycles; and a
final 10 min extension at 72 °C. Samples were purified with Agencourt AMPure XP
SPRI beads according to manufacturer’s instructions (Beckman Coulter, A63880)
and sequenced on a HiSeq2000 (Illumina).
sgRNA library cloning and lentiviral production. The AVANA-4 library
(74,700 sgRNAs targeting 18,675 genes and 1000 non-targeting sgRNA) was
provided by the Broad Institute Genetic Perturbation Platform. For the secondary
screen, a plasmid library containing 18,870 sgRNAs targeting the top 1000 ranked
genes from the primary screen and 787 genes from cross-validation analysis as well
as 1000 non-targeting sgRNAs was synthesized as oligonucleotides (Broad Institute
Biotechnology Lab). The sgRNAs were cloned by Gibson Assembly into the
pLentiGuide-Puro vector. To produce lentivirus, 293T cells were plated in a 6-well
dish at 0.5 × 106 cells per well. Transfection was performed using TransIT-LT1
(Mirus) according to manufacturer’s protocol and virus was harvested 48 h post-
transfection.
Influenza A virus and VSV infection. A549 or NHLF cells were inoculated with
300l (6-well plate) or 2 ml (T75 flask) of influenza A virus at MOI 5 for 1 hour at
37° in serum-free DMEM. The cells were then washed and replaced with fresh
serum-free DMEM supplemented with 1% BSA for 16 h. Infection was subse-
quently monitored by FACS or plaque assay.
For VSV infection, A549 cells were inoculated with 300 μl (6-well plate) of VSV
virus at MOI 1 for 1 h at 37° in complete DMEM. The cells were then washed and
replaced with fresh DMEM for 16 h. Infection was subsequently monitored
by FACS.
Screen analysis. Read counts corresponding to each guide RNA were normalised
to reads per million and and log transformed. Quantile normalisation was per-
formed in R. In order to control for the marked heteroscedasticity (Fig. 1b), local z-
scores, for pools of values with different read counts, were calculated for sliding
bins of varying size. For any comparison of two samples from which n read counts
[x] and [y] are derived (for example, the flu-permissive and control FACS pools),
the null hypothesis is xi= yi, where i is the ranked position in the list of read
counts. The read count bin was determined from the shortest distance between any
point (xi, yi) and the line y= x. Lower (l) and upper (u) limits of n sliding bins of
size b were defined such that each bin contains b values:
● Where i < 0:5 ´ b, l= 0, u= b
● In the middle of the list, l ¼ i 0:5 ´ b, u ¼ iþ 0:5 ´ b
● Where n ið Þ< 0:5 ´ b, l ¼ n b, u= n
Z-scores were then calculated within each of these bins. p values were calculated
from the sum of z-scores for sgRNAs targeting a particular gene compared to a
density function modeled on an empirical distribution of possible combinations of
sgRNA z-scores permuted at least 1e8 times by randomly rearranging z-scores for
all sgRNAs in the screen. In order to minimize false negatives and maximize the
discovery power of our screen, we did not require more than one sgRNA per gene
to be significantly over-represented in the influenza virus-permissive FACS pool
(permissive set). We report an additional “robust” set of hits in which the empirical
p-value for a given gene, derived from the remaining sgRNAs after the sgRNA with
the greatest effect is removed (remainder p), is less than 0.05. FDRs were calculated
using the Benjamini-Hochberg method in scipy stats v1.1.0.
Meta-analysis by information content (MAIC). The MAIC algorithm seeks to
combine the information in a heterogeneous group of data sources, in the form of
lists of genes implicated in similar processes. It creates a data-driven information
weighting for each source to prioritise relevant information, and allows the sys-
tematic integration of both ranked and unranked gene lists.
In a superset A of m input sets fL1; L2; L3; :::Lmg, such as experimental data
sources, each input set contains n named entities fe1; e2; e3; :::eng, such as genes.
Each input set belongs to a particular type of data source, which may have its own
hidden biases. For example, siRNA affects some genes more than others, and some
proteins have a tendency to be highly-connected in protein-protein interaction
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13965-x
14 NATURE COMMUNICATIONS |          (2020) 11:164 | https://doi.org/10.1038/s41467-019-13965-x | www.nature.com/naturecommunications
networks. Hence each input set is assigned to one of K categories,
fC1;C2;C3; :::CKg. The algorithm begins with the assumption that a set of true
positives, T, exists, and that, for any entity e, membership of several data sets L
belonging to independent categories C increases the probability that e is a member
of T. Each one of the data sets Lj; j ¼ 1; :::;m, has three attributes:
1. set of nj entities Lj ¼ fej1; ej2; ej3; ::: ejnjg
2. a category, cj 2 fC1;C2;C3; :::CKg
3. a structure, rj 2 fR; Fg where R is ranked and F is flat, or not ranked.
A score value for each one of the genes in A which is based on the “popularity”
of the genes in the input datasets. A gene will get a higher score for being
represented in many different categories, as compared to being represented in
many different datasets at the same category.
Each input set L is assigned a weighting score w to quantify the evidence in e
that derives from membership of. The weighting score w is itself defined as the sum
of the scores assigned to each entity e within L. The starting value of s for any e is
arbitrary - any numerical value can be chosen, without altering the final scores. For
simplicity, the initial s for each e is set to 1. In order to prevent any single category
(C) of data from biasing the results, each entity draws only one score (the highest
score) from each category. If there is no score for this e in a particular C, the score
assigned will be zero. In each iteration, the score of an entity i in a given category k
is updated:
sik ¼ max wLj gij 2 Lj ^ cj ¼ Ck
n o
i ¼ 1; :::; n; k ¼ 1; :::;K
The score of an entity for this iteration is the sum of the scores in each one of the
categories.
si ¼
PK
k¼1
sik; i ¼ 1; :::; n
The weighting score given to a dataset is the square root of the average score of the
genes belongs to this dataset.
wLj ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiP
gi2Ljð Þsi
nj
r
These equations are iterated until the values for w for all input sets L are no longer
changing (ie. each value for wLj is changed within 0.01 compared with the previous
value.)
Some input data sources provide gene lists that are ranked according to the
strength or statistical significance of experimental results. With descending rank,
the probability that a given gene is a true positive result is expected to decrease.
This decline in information content is modeled by fitting exponential decay curve
to the measured information content at each position in a ranked list. The
information content is inferred from the MAIC algorithm by truncating the list at
every position and calculating a weighting (wLj ) for the list up to that point, as if it
were unranked. A specific weighting for each position in a ranked list is then
calculated from the exponential decay function specific to this list.
Code to run the MAIC algorithm, and an online service with a user interface is
present at https://baillielab.net/maic.
Evaluation of MAIC. In order to evaluate MAIC against existing methods, we built
a simulated data generator to generate ranked, unranked, and mixed data based on
the Thurstonian ranking model84 which ranks entities by figure Z in descending
order for each entity generated from Gaussian distribution with mean value μ and
variance of the square of σ. Then we cut the generated lists by leaving only 0.5% (2)
entities and labeled the list as ranked or unranked. The total ratio for real entities
among all entities is also 10% in this evaluation. In the case of the present work, an
entity is a protein-coding gene in the human genome. We use the term “entity”
here because the approach is generalizable to a broad range of applications.
For List_i (i= 1…n), Entity_k (k=1…m), mean_noise M, the score Z for
Entity_k is:
Zk  N μk; σ2i
 
Log σ ið Þ ¼ log Mð Þ þ t
t  N 0; h2 
D ¼ h2
We used MAIC, robust tank aggregation (RRA)37, and a simple vote counting (VC)
method ranking entities by frequency on this model. We used top-25 overlap ratio
(classification accuracy) as the metric of success, comparing the top-25 entities of
result with top-25 true entities ranked by μk.
In evaluation experiments we tested MAIC against RRA and VC over the
following variations in synthetic input data:
(1) Noise: setting mean noise M (defining mean quality of lists instead of mean
numerical value of σ) among input lists. M was varied in the range
[0,0.1,0.5,1,3,12], from perfect data without noise to data with very
high noise.
(2) Heterogeneity: setting D [0 to 3] to show variability of the quality of input
lists, in order to model the real-life scenario in which data quality and
relevance from different experiments is expected to vary widely. D is varied
from 0 (indicating the same noise level (data quality) for all lists) to 3
(indicating very heterogeneous noise levels among the input lists).
Importantly, heterogeneity is varied independently of the average noise
among all input lists.
(3) Ranked:unranked ratio: setting the ratio of the number of ranked lists to be
50% and 100%, leaving the remaining lists as unranked.
Gene set enrichment analysis (MAIC output). Gene set enrichment analysis was
performed on gene MAIC score ranks, using package ‘fgsea’ in R version 3.5.2. 106
permutations were used to derive p-values, and the Benjamini-Hochberg method
was used to control false discovery rate (<0.05). The following gene set libraries
were queried: KEGG 2016, BioCarta 2016, Reactome 2016, WikiPathways 2016,
NCI Nature 2016, GO Biological Process 2018, GO Molecular Function 2018 and
GO Cellular Component 2018. Reference for FGSEA (note no PMCID yet as only
on bioRxiv): Sergushichev A (2016). “An algorithm for fast preranked gene set
enrichment analysis using cumulative statistic calculation.” bioRxiv. https://doi.org/
10.1101/060012, http://biorxiv.org/content/early/2016/06/20/060012.
Validation of individual hits using gene-specific CRISPR sgRNA. For validation
of individual hits in A549 cells, the two best sgRNAs from the AVANA-4 library
were cloned into pLentiCRISPR-V2 and lentivirus was produced from 239T cells as
described above. A549 Cells were transduced and selected with 1 μg/μl Puromycin
for 8 days and genome-editing was confirmed by deep sequencing and CRISPResso
analysis. For validation in NHLF cells, sgRNAs were cloned into pXPR_004, which
carries eGFP instead of Puromycin resistance gene. Following transduction, GFP+
NHLF cells were sorted by FACS. GFP+ cells were infected with influenza A virus
for 16 h at MOI5 and stained for surface HA using anti-influenza A HA antibody
(AB1074).
Rescue and over-expression of the KO genes. For the rescue experiment, A549
cells were transduced with pLentiCRISPR-V2 expressing a gene-specific sgRNA
together with a XPR101_rescue plasmid expressing Flag-tagged codon-mutated
version of the gene. Cells were selected with 1 μg/μl Puromycin and 10ug/ul
Blasticidin for 8 days. Expression of the add-back gene was confirmed by Western
Blot. To test if the genes of interest have redundant functions, A549 cells were
transduced with different combinations of the gene-specific sgRNAs and codon-
mutated versions of the genes. To test the effect of over-expressing the genes alone,
A549 cells were transduced with the rescue plasmids in the absence of sgRNAs.
Flow cytometry. Cells were stained with antibodies in PBS+ 1% BSA for 30 min
on ice and fixed with 4% paraformaldehyde. For intracellular staining for Influenza
A nucleoprotein (NP), cells were fixed and permeabilized using 0.1% Saponin
(Sigma Aldrich) prior to antibody staining. Data were acquired on the BD Accuri
(Bd Bioscience) and analyzed by FlowJo software (TreeStar).
Western blotting. To check for expression of WDR7, CCDC115, TMEM199, and
CMTR1 expression in rescue experiments, 5 × 105 transduced cells were washed
with ice-cold PBS and lysed in RIPA buffer (Thermofisher) supplemented with
EDTA-free Protease inhibitor cocktail (Roche). Cell lysates were span at 12,000
rpm in a microcentrifuge for 10 min at 4 °C and denatured by heating at 95 °C in
SDS loading buffer+DTT. Proteins were separated on a NuPAGE Novex 12%
Tris-Glycine gel and transferred to a polyvinylidene difluoride membrane (Mili-
pore). Immunoblotting was performed according to standard protocols using
Rabbit Anti-Flag primary antibody and HRP-conjugated anti-rabbit secondary
antibody.
To check for TFEB and Phospho-TFEB expression, cytoplasmic and nuclear
proteins were extracted from 5 × 105 cells using the NE-PER Nuclear and
Cytoplasmic Extraction reagents (Thermo Scientific) according to manufacturer
protocol. Immunoblotting was performed according to standard protocols using
anti-TFEB and anti-phospho-TFEB primary antibodies and HRP-conjugated anti-
rabbit secondary antibody.
RNA-extraction and qPCR. Total RNA was extracted from 1 × 105 cells using the
RNeasy Mini Kit (Qiagen) according to manufacturer’s protocol. First strand
cDNA synthesis was performed using 500 ng of total RNA with the Superscript III
First-strand Synthesis system with Oligo(dT) (Thermofisher). Quantitative qPCR
was performed using the Q5 hot start high fidelity polymerase and SYBR green I
Nucleic Acid Gel stain (Thermofisher) on the Roche 480 Light Cycler (Roche).
Human GAPDH was used as reference normalization control and expression levels
were quantified by the delta Ct method. Primer sequences are as follow:
Human IFN- β
F: 5′ – TGCTCTCCTGTTGTGCTTCT-3′
R:5′ – ATAGATGGTCAATGCGGCGT-3′
Influenza PR8 NP
F: 5′ – ATCGGAACTTCTGGAGGGGT-3′
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R:5′ – CAGGACTTGTGAGCAACCGA-3′
Influenza PR8 NS1
F: 5′ – GTCTGGACATCGAGACAGCC-3′
R:5′ – GAGTCTCCAGCCGGTCAAAA-3′
Influenza A/New Caledonia/1999 HA
F: 5′ – TCACCCGCCTAACATAGGGA-3′
R:5′ – TGCAAAAGCATACCATGGCG-3′
Influenza A/California/2009 HA
F: 5′ – GGACACTAGTAGAGCCGGGA-3′
R:5′ – CAATCCTGTGGCCAGTCTCA-3′
Influenza A/Vietnam/2005 HA (H5N1)
F: 5′ – TGAGCGCAGCATGTTCCTAT-3′
R:5′ – GCCCGTTCACTTTGGGTCTA-3′
Human GAPDH
F: 5′ – GGGAGCCAAAAGGGTCATCA-3′
R:5′ – AGTGATGGCATGGACTGTGG-3′
RNA sequencing. Transcriptomic analysis was performed using the Smart-Seq2
protocol. Total RNA was extracted using the RNeasy Mini Kit (Qiagen). cDNA was
synthesized from 1 ng of total RNA using the SuperScript III reverse transcription
system, followed by PCR pre-amplification and quality check using high-sensitivity
DNA Bioanalyzer chip (Agilent). 0.15 ng of pre-amplified cDNA was then used for
the tagmentation reaction carried out with the Nextera XT DNA sample pre-
paration kit (Illumina) and final PCR amplification. Amplified library was
sequenced on a Nextseq 500 (Illumina). For data analysis, short sequencing reads
were aligned using Bowtie and used as input in RSEM to quantify gene expression
levels for all UCSC hg19 genes. Data were normalized and analyzed using the R
software package DESeq2.
Plaque assays. A549 or NHLFs cells were infected with Influenza A PR8 or Udorn
virus at MOI 0.1 in serum-free DMEM supplemented with 1% BSA and 1 μg/μl
TPCK trypsin. 48 h post-infection, supernatant was collected and serial-diluted.
Two hundred microliters of the diluted supernatant was used to infect MDCK cells
on 6-well plates and the number of plaques were counted after 72 h. The virus titer
was calculated in Plaque forming units (PFU)/ml.
Proliferation assays. A549 cells were transduced with pLentiCRISPR-V2
expressing sgRNA against genes of interest and selected with 1 μg/μl Puromycin
for 2 days. On day 3, 5000 puromycin resistant cells were re-seeded on 6-well
plates and changes in total cell number were monitored on day 5, 7, and 9. On
day 9, some cells were harvested for ALAMAR Blue assay (Thermofisher,
DAL1025) and Annexin V staining (Thermofisher, V13241) according to
manufacturer protocol.
MLV-GFP pseudovirus production and entry assay. MLV-GFP pseudovirus was
produced by transfecting 1 μg of MLV Gag-pol plasmid, 1 μg of GFP plasmids,
0.3ug of Influenza PR8 HA plasmid, 1.2 μg of NA plasmid or 1.2 μg of MLV-Env
plasmid into 293T cells seeded on 6-well plate at 0.5 × 106 cells per well. Virus was
harvested and filtered 48 h post-transfection. To test for entry, A549 cells were
spinoculated with the pseudovirus at 2000 rpm for 30 min. Before cell transduction,
pseudovirus was incubated with 1ug/ml TPCK-treated trypsin for 1 h at room
temperature and then mixed with trypsin-neutralizing solution. GFP expression
was monitored 48 h post-spinoculation by FACS.
Influenza A virus binding assay. Cells were seeded on 6-well-plates and inocu-
lated with Influenza A PR8 virus at MOI 100 for 30 minutes at 4 °C. Cells were then
washed twice with ice cold PBS and stained for surface HA using anti-influenza A
HA antibody (AB1074).
Measuring level of cell surface sialic acid. Cells were stained with Sambucus
Nigra lectin (SNA) (Vector Laboratories Inc.) according to manufacturer protocol.
Briefly, Cells were incubated with 10ug/ml FITC-conjugated Lectin at room tem-
perature for 30 min. They were then washed twice in PBS and analyzed by FACS.
Fluorescent-in situ-hybridization (FISH). 1 × 105 cells were seeded on a cham-
bered cover glass (VWR, Nunc Lab-Tec 2 wells) pre-treated with 0.1 mg/ml poly-
D-lysine. The cells were infected with Influenza A PR8 virus the following day for
4 h at 37°. and then fixed and stained with Stellaris Quasar 570 RNA FISH probes
against Influenza A PR8 NP RNA according to manufacturer protocol (LGC
Biosearch Technologies). Images were taken on the Olympus FV1200 IX83 con-
focal microscope and percentage of RNA+ cells relative to the total number of cells
was quantified.
Confocal microscopy. Cells were imaged on the Olympus FV1200 IX83 laser
scanning confocal microscope equipped with a 40X objective and LD559, LD635
and LD405 (Olympus Life Science). Images were taken using the Olympus FV
software and analyzed using ImageJ. For imaging of lysotracker red, Lysosensor
blue, Oregon Green Dextran, Rab7 and LAMP1, 1 × 105 A549/NHLF cells were
seeded onto chambered cover glass (VWR, Nunc Lab-Tec 4 wells) pre-treated with
0.1 mg/ml poly-D-lysine the day before. They were treated with 100 nM lysotracker
dye for 1 h at 37 °C, followed by fixation with 4% paraformaldehyde and per-
meabilization with 0.1% Saponin. The cells were blocked with PBS with 1% BSA
and 0.1% Tween20 for 1 h at room temperature and stained with anti-Rab7 and
anti-LAMP1 antibodies overnight at 4 °C. The cells were then stained with sec-
ondary Alexa-fluor488-conjugated goat anti-mouse IgG antibody and DAPI for 1 h
at room temperature. Images were acquired with a ×40 objective using the setup
described above.
For visualization of Influenza NP localization within the cells, A549 cells were
infected with Influenza A PR8 virus at MOI 200 for 2 h at 37°. Infected cells were
then fixed with 4% paraformaldehyde and stained with FITC anti-influenza A NP
antibody overnight at 4°. The next day cells were washed, stained with DAPI for 1 h
at room temperature and images were acquired as described above.
Measuring lysosomal degradation of DQ-BSA. 1 × 105 A549 cells were seeded
on 12-well plates and incubated with 20ug/ml DQ Green BSA (Thermofisher,
D12050), 100 nM Lysotracker Red and DAPI for 1 h at 37 °C. The cells were then
washed in PBS and fixed in 4% paraformaldehyde. Confocal microscopy Images
were acquired with a ×40 objective using the setup described earlier.
Luciferase reporter assay for influenza A virus replication. To measure viral
polymerase activity, we utilized a vRNA-luciferase reporter system. Briefly, A549
cells were transfected with a vRNA reporter plasmid expressing firefly luciferase
under a viral UTR. The cells were also transfected with influenza A virus PA, PB1,
PB2, NP, and Renilla. Twenty-four hours post-transfection, cells were lysed and
mixed with Dual Glo substrate (Promega) according to Manufacturer’s protocol.
Luminescence was measured and quantified using a Synergy H1 multi-mode
microplate reader (BioTek).
In vivo cross-linking coupled immunoprecipitation with anti-eIF4E antibody.
Cells were harvested and cross-linked with 0.3% formaldehyde in culture media
for 10 min at 37 °C to enable high stringency washes of the in vivo protein-RNA
complexes63,85. Cells were washed three times with PBS and then fractionated
into nuclear and cytoplasmic fractions. Extracts from the two fractions were
combined and treated with Turbo DNase I (Ambion) and RNase inhibitor
(NEB) prior to pre-clearing using protein-G agarose to remove non-specific
contaminants that bind agarose. Anti-eIF4E (Cell Signaling) was used for
immunoprecipitation. The immunoprecipitates were subject to heat inactivation
at 56 °C for 15 min before subjecting to RNA isolation with 3 volumes of Trizol
(Invitrogen).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
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